Daniel Faga, Chief Business Officer at Spark Therapeutics, Inc. (ONCE), sold 7,500 shares at $79.95 ($607K) on 2017-10-20, disclosed to the SEC on 2017-10-24.
Open-market sale of $607k ONCE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.95 | 6,000 | $480K | 79.0% |
| 2 | $85.00 | 1,500 | $128K | 21.0% |
| Total | $80.96 avg | 7,500 | $607K | 100% |
| Filing → |
| ANAB | SELL | 2026-01-08 | $415K | — | Filing → |
| ANAB | SELL | 2026-01-06 | $662K | — | Filing → |
| ANAB | SELL | 2024-03-26 | $6.8M | — | Filing → |